Diaphragm Ultrasound to Predict Weaning Outcomes in Mechanically Ventilated Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03480828 |
|
Recruitment Status :
Completed
First Posted : March 29, 2018
Last Update Posted : March 30, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Accuracy of DE and DTF in Prediction of Extubation Success | Diagnostic Test: comparaison between DE and DTF in prediction of extubation success |
This trial enrolled all the adult patients who were mechanically ventilated for more than 48 hours and met all creteria for extubation. Patients who needed reintubation for upper aiway obstruction, neurological or hemodynamic alteration were excluded. The diaphragm ultrasound was performed during spontaneous breathing test or pressure support ventilation trial measuring the dipahragmatic excursion (DE) and the diaphragm thickening fraction (DTF) whithin 24 hours before extubation. The investigators compared the median values of DE and DTF in the group of successfully extubated patients and the group of patients who needed reintubation.
Our study compared the utility of DTF and DE to predict extubation success.
| Study Type : | Observational |
| Actual Enrollment : | 36 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Diaphragm Ultrasound to Predict Weaning Outcomes in Mechanically Ventilated Patients |
| Actual Study Start Date : | April 1, 2017 |
| Actual Primary Completion Date : | December 31, 2017 |
| Actual Study Completion Date : | December 31, 2017 |
- Diagnostic Test: comparaison between DE and DTF in prediction of extubation success
diaphragm ultrasound and measurement of DE and DTF in patients meeting all extubation criteria during spontaneous breathing trial
- extubation success [ Time Frame: 48 hours after extubation ]comparaison between DE and DTF values in successfully extubated patients
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- patients who were mechanically ventilated for more than 48h and meeting all criteria for extubation
- patients without history of neuromuscular disease, or severe chronic respiratory failure
Exclusion Criteria:
- patients who needed reintubation for upper airway obstruction or neurological or hemodynamic instability
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03480828
| Tunisia | |
| Mongi Slim Hospital | |
| La Marsa, Tunis, Tunisia, 2046 | |
| Principal Investigator: | Mhamed Sami Mebazaa, Professor | Mongi Slim Hospital |
| Responsible Party: | Mhamed Sami Mebazaa, Professor head of the anesthesia and intensive care department, Mongi Slim Hospital |
| ClinicalTrials.gov Identifier: | NCT03480828 |
| Other Study ID Numbers: |
rea1 |
| First Posted: | March 29, 2018 Key Record Dates |
| Last Update Posted: | March 30, 2018 |
| Last Verified: | March 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

